Pellizzari Christine A
SEC insider (Form 3/4/5 filer). CIK 0001127430. Director at Imunon, Inc. (IMNN) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 31, 2026. Located in LAWRENCEVILLE, NJ.
Companies Pellizzari Christine A has filed insider reports for
- Imunon, Inc. (IMNN): Director
- NeuroSense Therapeutics Ltd. (NRSN): Director
- Tempest Therapeutics, Inc. (TPST): Director
Pellizzari Christine A
CIK: 0001127430
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jul 31, 2026IMNN
Imunon, Inc.
AwardDirect6.9K shares at avg. $1.59$11K - May 22, 2026IMNN
Imunon, Inc.
AwardDirect5.6K shares at avg. $2.20$12K - Jan 27, 2026TPST
Tempest Therapeutics, Inc.
AwardDirectStock Option (right to buy)
1.2K shares- - Jan 2, 2026IMNN
Imunon, Inc.
AwardDirectStock Option (Right to Buy)
4.8K shares- - Aug 4, 2025IMNN
Imunon, Inc.
AwardDirect2.2K shares at avg. $9.20$21K - Mar 14, 2025IMNN
Imunon, Inc.
AwardDirectStock Option (Right to Buy)
3.8K shares- - Sep 6, 2024IMNN
Imunon, Inc.
AwardDirectStock Option (Right to Buy)
5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2026 |  IMNN Imunon, Inc. | Award | 6,934 | $1.59 | $11,025 | Direct |
| May 22, 2026 | IMNN Imunon, Inc. | Award | 5,557 | $2.20 | $12,225 | Direct |
| Jan 27, 2026 |  TPST Tempest Therapeutics, Inc. | Award Stock Option (right to buy) | 1,230 | - | - | Direct |
| Jan 2, 2026 | IMNN Imunon, Inc. | Award Stock Option (Right to Buy) | 4,827 | - | - | Direct |
| Aug 4, 2025 | IMNN Imunon, Inc. | Award | 2,248 | $9.20 | $20,682 | Direct |
| Mar 14, 2025 | IMNN Imunon, Inc. | Award Stock Option (Right to Buy) | 3,750 | - | - | Direct |
| Sep 6, 2024 | IMNN Imunon, Inc. | Award Stock Option (Right to Buy) | 4,964 | - | - | Direct |
1-7 of 7 transactions